Clinical trial
MRI Biomarkers of Effective Tissue Reperfusion After Thrombectomy of an Acute Proximal Occlusion of the Anterior Circulation: MR-Reperfusion Longitudinal Study
NCT04952077 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MRI Biomarkers of Effective Tissue Reperfusion After Thrombectomy of an Acute Proximal Occlusion of the Anterior Circulation: MR-Reperfusion Longitudinal Study
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 15, 2023
- Completion date
- December 31, 2024
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic stroke, acute